Epicrispr Biotechnologies, Inc.
1 clinical trials · Sponsor
◉ Watch Epicrispr Biotechnologies, Inc.
| Record | Firm | Date |
|---|---|---|
| A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy (NCT06907875) | Epicrispr Biotechnologies, Inc. | 2025-05-08 |
Track Epicrispr Biotechnologies, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.